The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Is The Estimated Growth In Market Size Of The Candin Market During 2026–2030?
Historical expansion was propelled by the increasing demand for immune competency assessment, the widespread adoption of delayed-type hypersensitivity (DTH) testing methods, the expansion of hospital diagnostic capabilities, a rise in immunosuppressive therapies, and the general growth of clinical immunology.
During the projected period, the anticipated growth is largely due to the increasing prevalence of immunodeficiency, the expansion of immune monitoring protocols, a rise in diagnostic testing volumes, improved clinical awareness, and developments in healthcare infrastructure. Key trends expected in this forecast timeframe include the expanding use of immune function diagnostic tests, broader assessment of cell-mediated immunity, a growing demand for diagnostic skin testing, an increased focus on detecting immunosuppressive disorders, and the reinforcement of hospital-based diagnostic services.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20011&type=smp
Which Strategic Drivers Are Supporting The Candin Market Development?
The rising occurrence of tuberculosis is projected to boost the expansion of the candin market in the future. Tuberculosis (TB), a contagious infectious condition caused by the bacterium Mycobacterium tuberculosis, primarily impacts the lungs but can spread throughout the body, transmitting via airborne droplets from infected individuals. The increase in tuberculosis cases stems from factors such as heightened transmission from undiagnosed or untreated individuals, the emergence of drug-resistant TB strains, deficiencies in healthcare access, population displacement, and the influence of co-infections like HIV that compromise immunity. Candin aids in addressing tuberculosis by functioning as a control in skin tests to assess cell-mediated immunity, differentiating between immune responses induced by Mycobacterium tuberculosis and nonspecific anergic reactions in individuals suspected of having tuberculosis or those with weakened immune systems. For example, in November 2024, the Centers for Disease Control and Prevention, a US-based national public health organization, reported 9,633 tuberculosis cases in the United States in 2023, representing a 15.6% increase from the 8,332 cases recorded in 2022. Consequently, the rising prevalence of tuberculosis is fueling the growth of the candin market.
Candin Market Driver: Impact Of Personalized Medicine On The Growth Of The Candin Market
How Is The Candin Market Structured Across Different Market Segments?
The candin market covered in this report is segmented –
1) By Indication: Candidiasis, Thrush
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
3) By End Use: Hospitals, Clinics, Ambulatory Care, Home Care
What Trends Are Affecting The Candin Market Dynamics?
A primary trend within the candin market involves concentrating on forming strategic alliances to provide non-invasive, economical, and efficacious treatment solutions. Such partnerships signify cooperative arrangements between multiple entities designed to utilize their respective strengths, assets, or specialized knowledge for achieving common objectives, frequently entailing shared risks, benefits, and duties across domains like product creation, market growth, or pioneering advancements. An illustrative example occurred in May 2023 when Nielsen BioSciences Inc., a US-based pharmaceutical firm, disclosed its entry into a licensing accord with Maruho Co. Ltd., a Japan-based pharmaceutical enterprise, enabling the sale of candin in Japan as a treatment for verruca vulgaris. Consequently, this collaboration will see Maruho provide a substantial upfront payment to Nielsen and assume full responsibility for all expenditures associated with the ongoing development and regulatory processes for Candin, which is a diagnostic skin test intended for treating verruca vulgaris (common warts).
Which Companies Are Engaged In The Candin Market Environment?
Major companies operating in the candin market are Nielsen BioSciences Inc.
Access The Complete Candin Market Report:
https://www.thebusinessresearchcompany.com/report/candin-global-market-report
What Is The Largest Regional Market In The Candin Market?
North America was the largest region in the candin market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the candin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model